Metformin, the most prescribed drug for treating diabetes mellitus, known as type 2 diabetes, requires the presence of the growth differentiation factor 15 (GDF15) —a protein whose expression increa...
Read moreScientists at IRB Barcelona detail the DNA binding mechanism of FoxH1, a protein involved in embryonic development and in some tumour processes.
Read moreThe CNIO group analyzed HER2-negative breast cancer samples from 130 patients treated with paclitaxel, one of the most widely used drugs against breast, ovarian, lung, bladder, prostate, melanoma, eso...
Read moreResearchers from the Institute for Bioengineering of Catalonia (IBEC) have developed the most complete atlas up to date with the genetic mutations that causes the formation of amyloid beta fibril, a p...
Read moreArtificial intelligence (AI) is constantly bringing improvements to the field of medical devices, with AI technology being embedded in software used as a medical device or being a medical device by it...
Read moreLa braquiterapia de mama está indicada, sobre todo, para casos de cáncer de mama en los que el tumor no es muy grande y en los que no hay afectación de los ganglios linfáticos.
Read moreL;os pacientes con esclerosis lateral amiotrófica (ELA) presentan niveles anormalmente elevados de las proteínas NOD2 y Spp1, por lo que estas moléculas se postulan como nuevos biomarcadores en la ...
Read moreA study by the hospital Clínic Barcelona-IDIBAPS, published in the journal Neurology, confirms the usefulness of a blood-based biomarker to diagnose Alzheimer’s disease without the need for more in...
Read moreResearchers at Pulmobiotics, a start-up founded in 2020 at the Centre for Genomic Regulation (CRG) in Barcelona, have begun work on a ‘living medicine’ to improve the efficacy of lung cancer treat...
Read moreUno de los subtipos más comunes de melanoma es causado por mutaciones en NRAS, una proteína relacionada con la malignidad de las células que se halla alterado en un 25% de los casos. Su tratamiento...
Read moreOryzon Genomics presents the final data from its Phase IIa ALICE trial, investigating iadademstat in combination with azacitidine in elderly or unfit patients with acute myeloid leukemia (AML), at the...
Read moreThe Molecular Neuropharmacology research group, coordinated by Olga Pol at the Sant Pau Biomedical Research Institute and the UAB Institute of Neurosciences, is looking for new therapeutic possibiliti...
Read more